CETP inhibitor, JTT-705, Purity ≥98%

Cat. No.: X24-09-YM275

CETP inhibitor, JTT-705, Purity ≥98%

Synonym: 211513-37-0; JTT705; Dalcetrapib; JTT 705; RO-4607381; RO4607381; JTT705; JTT 705; S-[2-[[1-(2-Ethylbutyl)cyclohexanecarbonyl]amino]phenyl] 2-methylpropanethioate; CETP inhibitor

  • MDL: MFCD06407886
  • CAS Number: 211513-37-0
  • Compound CID: 6918540
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
JTT-705, soluble in DMSO and ethanol and insoluble in water, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting CETP. The molecular weight of the compound is 389.6, and its molecular formula is C23H35NO2S. It targets the rhCETP.
Molecular Weight
389.6
Molecular Formula
C23H35NO2S
Targets
rhCETP
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Solubility
In vitro: DMSO: 66 mg/mL (169.41 mM); Water: insoluble; Ethanol: 66 mg/mL (169.41 mM); In vivo: 0.5% methylcellulose, 28 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
JTT-705 plays a key role in helping increase HDL cholesterol levels and decrease LDL cholesterol levels, which may be beneficial in managing hyperlipidemia and reducing cardiovascular risk.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0